BioSpace News Archive

Technavio has announced its latest market research report titled global cholangiocarcinoma therapeutics market 2019-2023.

Technavio has announced its latest market research report titled global colorectal cancer therapeutics market 2019-2023.

Zebra Medical Vision and Clalit Health Services announce the completion of a medical study that showcases how algorithms can be used to utilize existing CT data to identify patients at high risk for osteoporotic fractures.

GlaxoSmithKline plc (LSE/NYSE: GSK) announced the US Food and Drug Administration (FDA) granted a priority review for the company’s Biologics License Application (BLA) seeking approval of belantamab mafodotin (GSK2857916) for the treatment of patients with relapsed or refractory multiple myeloma whose prior therapy included an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody.

Miach Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, announced that Stephen Wohlert, PhD, has joined the company as vice president of manufacturing.

Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases, reported that it has entered into a definitive “reverse merger” agreement with Qualigen, Inc. (“Qualigen”)

AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy devices that treat cancer-related lymphedema and venous complications, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its updated AIROS 8 Sequential Compression Therapy device and garment system.

REVIAN Inc. (formerly PhotonMD Inc.) – a medical technology company dedicated to stimulating the body’s natural processes to rejuvenate hair and skin with light – is excited to announce that final data from a randomized, double-blind study of the REVIAN RED hair growth system was presented at the 2020 Winter Clinical Dermatology Conference - Hawaii®.

Henry Schein Earns 100 Percent on the Human Rights Campaign Foundation’s Annual Scorecard Assessing LGBTQ Workplace Equality

Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties.